Lanying Guo

Dr. Lanying Guo

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 May 2021 in Nanomaterials
Verified
Journal Article
Open access
PDF file
LGLanying Guo
Lanying Guo
JPJiantao Ping
Jiantao Ping
JQJinglei Qin
Jinglei Qin
MYMu Yang
Mu Yang
XWXi Wu
Xi Wu
Hongshang PengHongshang Peng
Hongshang Peng
Although hollow mesoporous silica nanoparticles (HMSNs) have been intensively studied as nanocarriers, selecting the right HMSNs for specific drugs still remains challenging due to the enormous diversity in so far reported HMSNs and drugs. To this end, we herein made a comprehensive study on drug loading in HMSNs from the viewpoint of impacting factors and loading efficiency. Specifically, two types of HMSNs with negative and positive zeta potential were delicately constructed, and three categories of drugs were selected as delivery targets: highly hydrophobic and lipophobic (oily), hydrophobic, and hydrophilic. The results indicated that (i) oily drugs could be efficiently loaded into both of the two HMSNs, (ii) HMSNs were not good carriers for hydrophobic drugs, especially for planar drugs, (iii) HMSNs had high loading efficiency towards oppositely charged hydrophilic drugs, i.e., negatively charged HMSNs for cationic molecules and vice versa, (iv) entrapped drugs would alter zeta potential of drug-loaded HMSNs. This work may provide general guidelines about designing high-payload HMSNs by reference to the physicochemical property of drugs.

30 May 2022 in Chemosensors
Verified
Journal Article
Open access
PDF file
TYTingyu Yang
Tingyu Yang
JQJinglei Qin
Jinglei Qin
JZJinling Zhang
Jinling Zhang
LGLanying Guo
Lanying Guo
MYMu Yang
Mu Yang
Hongshang PengHongshang Peng
Hongshang Peng
Fluorescent bio/chemosensors are widely used in the field of biological research and medical diagnosis, with the advantages of non-invasiveness, high sensitivity, and good selectivity. In particular, luminescent bio/chemosensors, based on lanthanide nanocrystals (LnNCs) with a second near-infrared (NIR-II) emission, have attracted much attention, owing to greater penetration depth, aside from the merits of narrow emission band, abundant emission lines, and long lifetimes. In this review, NIR-II LnNCs-based bio/chemo sensors are summarized from the perspectives of the mechanisms of NIR-II luminescence, synthesis method of LnNCs, strategy of luminescence enhancement, sensing mechanism, and targeted bio/chemo category. Finally, the problems that exist in present LnNCs-based bio/chemosensors are discussed, and the future development trend is prospected.

13 August 2025 in Chemnanomat
Verified
Journal Article
Closed access
LGLanying Guo
Lanying Guo
CPCaiming Pan
Caiming Pan
JPJiantao Ping
Jiantao Ping
PRPengfei Ren
Pengfei Ren
ZXZhengyuan Xu
Zhengyuan Xu
Hongshang PengHongshang Peng
Hongshang Peng

5 October 2026 in iScience
Verified
Journal Article
Open access
WXWeifan Xu
Weifan Xu
XPXing Pang
Xing Pang
YZYingli Zhu
Yingli Zhu
LGLanying Guo
Lanying Guo
JZJinsong Zhao
Jinsong Zhao
PRPengfei Ren
Pengfei Ren
Uncontrolled hemorrhage remains a major cause of preventable death in trauma and surgery, yet the performance of hemostatic materials varies markedly with wound geometry, blood flow, coagulation status, and tissue sensitivity. This review critically examines natural polymer-based, synthetic polymer-based, inorganic, and composite hemostats by linking material structure to six principal mechanisms: fluid absorption and surface adsorption, coagulation activation, bioactive-factor delivery, photothermal assistance, adhesive sealing, and microstructural regulation. Beyond cataloging materials, we compare class-specific advantages, failure modes, and safety constraints, and analyze how hemodilution, hypothermia, acidosis, anticoagulation, infection, and high-flow bleeding reshape material performance. We further integrate clinically used products, scenario-based material selection, and a staged evaluation framework spanning mechanistic assays, hostile-condition testing, translational bleeding models, rebleeding assessment, and post-hemostasis safety. Finally, we outline stage-matched pathways for responsive and multifunctional systems. This mechanism-scenario-evaluation framework supports more rigorous design, comparison, and clinical translation of next-generation hemostatic materials.